Compare Abbott Laboratories (ABT) vs Global X Cloud Computing ETF (CLOU) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Abbott Laboratories vs Global X Cloud Computing ETF — how do they compare? Abbott Laboratories trades at $95.62 (market cap $166.94B), while Global X Cloud Computing ETF trades at $23.58. The key difference: Abbott Laboratories pays a 2.63% dividend while Global X Cloud Computing ETF pays none, and Global X Cloud Computing ETF is trading nearer its 52-week high, Abbott Laboratories nearer its low. Which is the better fit depends on your goals.
| ABT | CLOU | |
|---|---|---|
Market Cap | $166.94B | — |
Sector | Health | Sector/Thematic |
52-Week High | $136.62 | $26.38 |
52-Week Low | $82.57 | $17.60 |
Enterprise Value | $193.69B | — |
Dividend Yield | 2.63% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Abbott Laboratories (ABT) trades at $95.63, up 0.25% on the day, with a bullish technical signal from moving averages and strong analyst support. The stock shows solid fundamentals with a P/E of 26.79 and net income margin of 13.91%, though recent earnings have been mixed. Recent news highlights regulatory approvals for new medical devices, supporting growth prospects.
The outlook remains positive with a consensus price target of $122.55, implying significant upside. Key risks include competitive pressures and macroeconomic headwinds, but strong institutional backing and consistent dividend payments provide stability for long-term investors.
CLOU trades at $23.43, up 0.9% today, with a bullish technical signal from moving averages but neutral oscillators. The ETF provides exposure to the cloud computing sector, though key valuation and profitability metrics are not disclosed in the provided data. Recent news highlights mixed performance for cloud ETFs, with some articles discussing growth potential from AI platforms while others note significant past losses in similar funds.
The outlook for CLOU hinges on broader technology and cloud computing trends, with AI adoption presenting a potential catalyst. Risks include sector volatility, competitive pressures, and regulatory developments, as seen in Europe's push for tech sovereignty. Investors should weigh the ETF's diversification benefits against the inherent uncertainties in the tech landscape.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Abbott Laboratories
Abbott manufactures and markets medical devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, molecular diagnostic platforms, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.
Read more on ABT →About Global X Cloud Computing ETF
CLOU is a thematic ETF that invests in companies leading the cloud revolution. It targets providers of SaaS, PaaS, and IaaS, including major firms like Salesforce, Akamai, and Shopify that drive modern digital infrastructure.
Read more on CLOU →
